tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market
CYCN
Cyclerion Therapeutics
RESEARCH TOOLSreports

Cyclerion Therapeutics (CYCN) Income Statement

267 Followers

Cyclerion Therapeutics Income Statement

Last quarter (Q4 2025), Cyclerion Therapeutics's total revenue was $1.02M, a decrease of -43.24% from the same quarter last year. In Q4, Cyclerion Therapeutics's net income was $-799.00K. See Cyclerion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.07M$ 2.00M$ 0.00$ 297.00K$ 3.32M
Gross Profit
$ 2.07M$ 2.00M$ 0.00$ -5.28M$ 3.32M
Operating Expenses
$ 7.05M$ 5.63M$ 12.95M$ 13.26M$ 58.52M
Depreciation and Amortization
$ 0.00$ 0.00$ 65.00K$ 65.00K$ 472.00K
EBITDA
$ -4.97M$ -3.63M$ -9.58M$ -18.48M$ -53.84M
Operating Income
$ -4.97M$ -3.63M$ -12.95M$ -18.54M$ -55.20M
Other Income/Expenses
$ 1.45M$ 571.00K$ 358.00K$ 294.00K$ 3.55M
Pretax Income
$ -3.53M$ -3.06M$ -12.59M$ -18.25M$ -51.65M
Net Income
$ -3.53M$ -3.06M$ -5.26M$ -44.08M$ -51.65M
Per Share Metrics
Basic EPS
$ -1.09$ -1.21$ -8.99$ -20.15$ -26.40
Diluted EPS
$ -1.09$ -1.21$ -8.99$ -20.15$ -26.40
Weighted Average Shares Outstanding
 3.23M 2.52M 2.34M 2.17M 1.96M
Weighted Average Shares Outstanding (Diluted)
 3.23M 2.52M 2.34M 2.17M 1.96M
Currency in USD

Cyclerion Therapeutics Earnings and Revenue History